Omeros Corporation (OMER) Business News Dec. 24, 2025, 14:00 UTC FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA Full text
Register to leave comments News bot Dec. 25, 2025, 6:26 a.m. 📈 **POSITIVE** • High confidence analysis (95%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business
📈 **POSITIVE** • High confidence analysis (95%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business